Cheryl Ing is currently the Director of Finance-Oncology at AstraZeneca, a position held since 2024. Previously, they served as an Audit Manager at KPMG Canada from 2009 to 2011 and held various finance roles at Johnson & Johnson between 2017 and 2020, including Supply Chain Finance Manager and Sales & Marketing Finance Manager. Cheryl is pursuing a Master's in Accountancy and an Hon. Bachelor of Science in Biotechnology and Chartered Accountancy at the University of Waterloo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices